ArticleTranslational cancer research2026
A prognostic model for head and neck squamous cell carcinoma based on eosinophil extracellular trap related genes.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Head and neck squamous cell carcinoma (HNSCC) is one of the most prevalent malignant tumors worldwide and presents significant challenges due to its high rates of recurrence, metastasis, and poor prognosis. Emerging evidence suggests that eosinophil extracellular traps (EETs)-related genes may play a crucial role in tumor progression and aggressiveness. Consequently, investigating the intersection between HNSCC and EETs-related genes and constructing a prognostic model may offer valuable clinical insights. This study aims to identify the key genes that play a significant role in the eosinophil extracellular trap of HNSCC, and to construct a prognostic model to guide treatment. Methods: We systematically analysed transcriptomic data from The Cancer Genome Atlas (TCGA) alongside clinical datasets to identify differentially expressed genes (DEGs) in HNSCC patients. Through comprehensive bioinformatics approaches, we identified genes intersecting between HNSCC DEGs and EETs-related genes. A prognostic model was constructed used the random forest algorithm and externally validated with data from the Gene Expression Omnibus (GEO). We further assessed the model's relationship with the tumor microenvironment (TME) and its association with drug sensitivity. Results: A total of 57 overlapping genes were identified. Using univariate Cox regression, least absolute shrinkage and selection operator (LASSO) regression, and multivariate Cox analysis, five key prognostic genes ( Conclusions: Patients stratified by risk score exhibited distinct immune cell infiltration patterns and drug sensitivity profiles. The EETs-related gene model may serve as a valuable biomarker for predicting prognosis and informing therapeutic strategies in HNSCC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.